We are very happy to announce that the call for Amsterdam UMC TKI-PPP grants is now open. The grant amounts available to both our UMCs will be combined, creating a pot of approximately 8-9 million euros that will be divided over the best TKI-research proposals that we will receive from all of you.
On September 30 a webinar was hosted by IXA to explain more in detail what the grant is about, what the requirements are and what the timeline and process entails. You can download the presentation of this webinar here or watch the webinar below.
For those of you who are unfamiliar with TKI grants and PPP-proposals, please click here to download the TKI-PPP flyer in which we explain all abbreviations, the details of the grant procedure, how proposals will be evaluated, and where the money comes from.
Those of you who have a proposal in mind and a private partner to collaborate with are invited to prepare and send in a pre-application using the form and budget sheet below no later than the deadline of November 20. In addition, a Letter of Intent from each private partner is required at this stage (see template below).
The Consortium Agreement (also below) comes in slightly different variants, depending on the number of industrial and/or academic partners. For now we have only attached a 1-on-1 version. Please provide your industrial partner(s) with this draft Consortium Agreement at an early stage, allowing your partner(s) to get acquainted with the conditions that they will need to accept once your joint application is awarded.
We look forward to receiving your proposals!
2. Budget form
Teachers from the department of medical informatics of Amsterdam UMC have developed an online platform to gather and visualize structured curriculum information, called act-E. Education managers, teachers and students use this platform to gain insights regarding their curricula that could never be viewed as easily before. These insights help them to have an informed conversation […]News
Chronic kidney diseases are a severe and growing worldwide problem with a lack of effective treatments often leading to dialysis, transplantation, and high costs to health care systems. Now, a monoclonal antibody, named BION-1301 (anti-APRIL), is being developed to treat patients with IgA nephropathy. BION-1301 is a potential disease-modifying approach to prevent the formation of […]News
VU alumni International Business Administration Michael Musandu and Ugnius Rimsa founded Lalaland in 2019. The startup generates and hyper personalizes full human body models from head to toe by using AI. As a result, models are available in different ethnicities, sizes and ages, allowing customers to always recognize themselves in the clothing of their choice. […]News